Q-switched Nd:YAG laser to treat nevomelanocytic nevi

<b>Background</b> : Q-switched Nd:YAG laser, a melanin pigment-specific laser was used to treat melanocytic nevi in Indian patients. <b> Objective</b> : To assess the clinical response of nevi to Q-switched Nd:YAG laser of 1064 nm wavelength. <b> Materials and Methods&l...

Full description

Bibliographic Details
Main Authors: Parasramani S, Oberai C, Amonkar K, Naik S
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2009-01-01
Series:Journal of Cutaneous and Aesthetic Surgery
Subjects:
Online Access:http://www.jcasonline.com/article.asp?issn=0974-2077;year=2009;volume=2;issue=2;spage=88;epage=91;aulast=Parasramani
id doaj-49b1ca6fad624c5b8566fe2d58b3841f
record_format Article
spelling doaj-49b1ca6fad624c5b8566fe2d58b3841f2020-11-24T21:07:38ZengWolters Kluwer Medknow PublicationsJournal of Cutaneous and Aesthetic Surgery 0974-20770974-51572009-01-01228891Q-switched Nd:YAG laser to treat nevomelanocytic neviParasramani SOberai CAmonkar KNaik S<b>Background</b> : Q-switched Nd:YAG laser, a melanin pigment-specific laser was used to treat melanocytic nevi in Indian patients. <b> Objective</b> : To assess the clinical response of nevi to Q-switched Nd:YAG laser of 1064 nm wavelength. <b> Materials and Methods</b> : Nineteen patients received an average of 2.57 treatments with Q-switched Nd:YAG laser of 1064 nm wavelength, repetition rate of 10 Hz, 10 nanoseconds pulse width, and spot size of 4 mm to 6 mm with a fluence ranging from 4 to 9.7 joules/cm<sup> 2</sup> . The clinical end point of the laser treatment was brisk whitening. The response was assessed by using a global assessment score. <b> Results</b> : The clinical global assessment score showed excellent response in 8/19 patients and good response in 6/19 patients. <b>Conclusion</b> : The Q-switched Nd:YAG laser of 1064 nm wavelength resulted in significant improvement (lightening) of nevi.http://www.jcasonline.com/article.asp?issn=0974-2077;year=2009;volume=2;issue=2;spage=88;epage=91;aulast=ParasramaniNevomelanocytic neviQ-switched Nd:YAG laserIndian
collection DOAJ
language English
format Article
sources DOAJ
author Parasramani S
Oberai C
Amonkar K
Naik S
spellingShingle Parasramani S
Oberai C
Amonkar K
Naik S
Q-switched Nd:YAG laser to treat nevomelanocytic nevi
Journal of Cutaneous and Aesthetic Surgery
Nevomelanocytic nevi
Q-switched Nd:YAG laser
Indian
author_facet Parasramani S
Oberai C
Amonkar K
Naik S
author_sort Parasramani S
title Q-switched Nd:YAG laser to treat nevomelanocytic nevi
title_short Q-switched Nd:YAG laser to treat nevomelanocytic nevi
title_full Q-switched Nd:YAG laser to treat nevomelanocytic nevi
title_fullStr Q-switched Nd:YAG laser to treat nevomelanocytic nevi
title_full_unstemmed Q-switched Nd:YAG laser to treat nevomelanocytic nevi
title_sort q-switched nd:yag laser to treat nevomelanocytic nevi
publisher Wolters Kluwer Medknow Publications
series Journal of Cutaneous and Aesthetic Surgery
issn 0974-2077
0974-5157
publishDate 2009-01-01
description <b>Background</b> : Q-switched Nd:YAG laser, a melanin pigment-specific laser was used to treat melanocytic nevi in Indian patients. <b> Objective</b> : To assess the clinical response of nevi to Q-switched Nd:YAG laser of 1064 nm wavelength. <b> Materials and Methods</b> : Nineteen patients received an average of 2.57 treatments with Q-switched Nd:YAG laser of 1064 nm wavelength, repetition rate of 10 Hz, 10 nanoseconds pulse width, and spot size of 4 mm to 6 mm with a fluence ranging from 4 to 9.7 joules/cm<sup> 2</sup> . The clinical end point of the laser treatment was brisk whitening. The response was assessed by using a global assessment score. <b> Results</b> : The clinical global assessment score showed excellent response in 8/19 patients and good response in 6/19 patients. <b>Conclusion</b> : The Q-switched Nd:YAG laser of 1064 nm wavelength resulted in significant improvement (lightening) of nevi.
topic Nevomelanocytic nevi
Q-switched Nd:YAG laser
Indian
url http://www.jcasonline.com/article.asp?issn=0974-2077;year=2009;volume=2;issue=2;spage=88;epage=91;aulast=Parasramani
work_keys_str_mv AT parasramanis qswitchedndyaglasertotreatnevomelanocyticnevi
AT oberaic qswitchedndyaglasertotreatnevomelanocyticnevi
AT amonkark qswitchedndyaglasertotreatnevomelanocyticnevi
AT naiks qswitchedndyaglasertotreatnevomelanocyticnevi
_version_ 1716762076910714880